Top 10 Health Supplements Companies

Why Health Supplements Market Is Expanding?

The Global Health Supplements Market is on a sustained growth trajectory, valued at USD 155.8 billion in 2025 and projected to reach USD 243.5 billion by 2035, registering a CAGR of 4.6% over the 2026--2035 forecast period. Market Research Future (MRFR) identifies two co-equal primary demand engines: the global shift toward preventive healthcare --- with 68% of adults in 15 major economies now incorporating supplements into daily wellness routines, up from 51% in 2019 --- and the structural aging of populations, with the UN projecting one in six persons worldwide will be aged 60 or older by 2030. The convergence of rising chronic disease burden, digital health infrastructure, and e-commerce channel expansion provides self-reinforcing tailwinds that sustain above-baseline growth well through the 2035 forecast horizon.

Vitamins command the largest product segment at approximately 29% of market share, anchored by immune and bone-health formulations.

Prebiotics & Probiotics is the fastest growing segment with a CAGR of 10.3% through 2035. This growth is supported by clinical research that establishes a relationship between gut microbiota diversity and immunological and cognitive performance. Capsules and tablets are the volume leaders, while gummies are gaining share at a 13.0% CAGR, as pectin-based matrices unleash vegan and halal market groups. Regionally, the Asia-Pacific region holds 38% of worldwide revenue driven by China’s Healthy China 2030 goal and Japan’s super-aging population while Middle East & Africa is the fastest expanding market driven by healthcare diversification strategies in Saudi Arabia and the UAE. Online / E-commerce channels are rising at a 7.8% CAGR, with the fastest growth driven by tailored recommendation algorithms and subscription ease.

Why These Companies Are Leading the Market?

MRFR identifies four structural factors that define category leadership in the Health Supplements Market: proprietary distribution architecture spanning direct-selling, pharmacy, and D2C channels; brand equity and third-party certification density that commands retail price premiums of 15--20%; vertical integration into plant-based and clean-label ingredient sourcing that insulates margins from raw-material volatility; and disciplined M&A strategy to acquire premium brands with subscription bases and proprietary formulation IP.

Amway and Herbalife Nutrition are leaders in the direct-selling network whose combined 3.5 million-plus independent distributors create a moat that digital-native D2C firms can’t reproduce at comparable cost-per-acquisition. Bayer and Haleon have the benefit of mass-market retail domination, with a pharmacy-focused distribution and brand recognition for Centrum, One A Day and Caltrate, giving them shelf-space power over more than 100,000 retail doors across the world. In institutional channels, Abbott Laboratories is defined by its clinical-grade stance with its physician-recommended and funded Ensure and PediaSure therapeutic nutrition lines.

Nestlé Health Science has built a nutrition platform through acquisition-led premium portfolio builds, including Garden of Life, Vital Proteins and Pure Encapsulations. Glanbia leads in the sports-nutrition focus, with its Optimum Nutrition brand having the most share in the performance segment. Blackmores and Swisse Wellness have Asia-Pacific heritage and naturopathic repute, and their TCM and Ayurveda-adjacent positioning taps into the fastest-growing regional demand.

Top 10 Global Health Supplements Companies --- MRFR Rankings (2026)

MRFR has identified and profiled the following leading health supplements companies globally, evaluated on the basis of revenue performance, geographic presence, brand portfolio breadth, distribution architecture, innovation investment, and consumer reach. Figures below have been validated against company filings, investor-relations disclosures, and official company websites as of June 2026.

*Rankings reflect MRFR's qualitative assessment of scale and market influence in the health supplements sector. Revenue figures are drawn from SEC filings and official investor disclosures where the company is publicly traded; figures for private companies are marked as undisclosed since none disclose audited segment revenue publicly.

Detailed Company Profiles

1. Amway (Nutrilite) | Private (family-owned) | Ada, Michigan, USA

Amway's structural advantage in the health supplements market is not product formulation but distribution architecture: a 3.5-million-plus independent distributor network that converts personal relationships into recurring revenue at customer acquisition costs that digital-native D2C brands cannot replicate. The company's Nutrilite brand --- the world's top-selling vitamin and dietary supplement brand by volume --- is backed by vertically integrated organic farming operations across Washington, California, Mexico, and Brazil, giving Amway supply-chain control over 70+ botanical ingredients.

Amway’s nutrition category gained 2% in 2024, as total revenue declined 3% to USD 7.4 billion, with nutrition now representing 64% of global sales. In 2024, we will debut Gut Health solutions, a combination of plant protein, fiber and probiotics, signaling a shift to microbiome-positioned bundles that enhance average order value per distributor. New CEO Michael Nelson, who took the helm in September 2024, is investing in infrastructure to improve manufacturing, quality control and R&D processes to fuel the next phase of growth.

2. Abbott Laboratories | NYSE: ABT | Abbott Park, Illinois, USA

Abbott's position in the health supplements market is defined by clinical-grade credibility rather than consumer brand awareness. The company's Nutritional Products segment generated USD 8.45 billion in FY2024 revenue, with adult nutrition sales up 8.0% and operating margin expanding to 17.9% --- a recovery narrative from the 2022 Sturgis facility recall that temporarily disrupted U.S. infant formula supply. Abbott's Ensure, Glucerna, and PediaSure lines are physician-recommended and frequently reimbursed through institutional channels, creating a switching-cost barrier that mass-market vitamin brands cannot penetrate.

The nutrition division accounted for almost 20% of the group’s total consolidated sales of USD 41.95 billion in FY2024. Abbott’s FY2024 R&D expenditure of USD 2.84 billion supports a pipeline of condition-specific nutritional therapeutics that straddle the supplement-medical food divide.

3. Bayer AG | XETRA: BAYN | Leverkusen, Germany

Geographically, Bayer’s Consumer Health division is the most entrenched player in the mass-market supplements category, with sales of EUR 5.87 billion in 2024, spread over more than 100 countries and brands such as One A Day, Elevit and Supradyn, which enjoy pharmacy-shelf leverage. The division’s results were mixed for 2024, with Dermatology up 9.7% and Digestive Health up 8.2%, offset by an 11.5% fall in Allergy & Cold in a soft respiratory season. Bayer’s strategic venture on gummy-format manufacturing, a dedicated EUR 200 million plant in Germany announced in April 2024, targets the 13.0% CAGR gummy category and positions the company to provide European and Middle Eastern markets with halal and vegan-certified pectin-based formulations. The Consumer Health EBITDA margin before special items was stable at 23.3% in 2024, showing careful cost control.

4. Haleon | LSE: HLN / NYSE: HLN | Weybridge, UK

The 2022 Haleon separation from GSK formed the world's largest standalone consumer health firm. Its VMS (Vitamins, Minerals & Supplements) portfolio -- led by Centrum, Caltrate, and Emergen-C -- is the world's most pharmacy-centric supplement franchise. In FY2024, Haleon recorded overall revenue of GBP 11.23 billion, which included organic growth of 5.0%, a consequence of high-single-digit growth in VMS and activation of Centrum’s cognitive-function claim. The January 2025 introduction of Centrum Silver+ in 28 markets with increased Vitamin K2 and magnesium glycinate for the 65-plus group highlights Haleon’s capacity to align global innovation with regional regulatory processes. The company has over 3.5 million relationships with health professionals, creating a recommendation-powered buying funnel that mass-retail brands can’t imitate. Haleon also increased its China joint-venture interest to 88% in 2024 for almost GBP 500 million, deepening exposure to the world's largest supplement market.

5. Herbalife Nutrition | NYSE: HLF | Los Angeles, California, USA

The company’s AI-powered recommendation platform, which was rolled out to 15 additional markets in October 2024, combines wearable health data to produce personalized supplement stacks, and its health supplement strategy is centered on personalized nutrition bundles distributed through a network of 2.8-million-plus independent distributors. Revenue for FY2024 contracted 1.4% y-o-y to USD 4.99 billion, while net income jumped 79% to USD 254.3 million as profit margin widened to 5.1% on the back of cost control from the restructuring. The company’s weight management and targeted nutrition categories remain the biggest revenue contributors, with sports nutrition gaining share with younger distributor cohorts. Herbalife’s 2025 acquisition of Pro2col, backed by an investment from Cristiano Ronaldo, is a sign of the celebrity-endorsement approach to standing out in the congested performance-nutrition category.

6. Nestlé Health Science | Subsidiary of Nestlé S.A. (SWX: NESN) | Vevey, Switzerland

Nestlé Health Science is the most acquisition-driven premium supplement platform in the market, having assembled Garden of Life (organic whole-food supplements), Vital Proteins (collagen), and Pure Encapsulations (practitioner-grade) into a portfolio that spans mass, premium, and clinical channels. While Nestlé S.A. does not separately disclose Health Science segment revenue, the group's CHF 92.9 billion FY2024 total revenue provides the capital base for continued M&A.

Nestlé’s acquisition of a fermented botanical ingredients startup for USD 340 million in March 2025 bolsters its plant-based supplement pipeline and vertical integration into clean-label sourcing --- a strategic necessity as plant-based supplements are growing at about twice the rate of synthetics. Nestlé’s global supply chain infrastructure and contacts with more than 500,000 retail doors give distribution leverage that premium brands alone cannot grow organically.

7. Glanbia | Euronext Dublin: GL9 | Kilkenny, Ireland

Glanbia’s health supplements' competitive positioning is in sports nutrition, not general wellbeing. The Optimum Nutrition brand has a dominant share of the worldwide performance supplements category, while Amazing Grass leads the plant-based superfood niche. The company announced FY2024 revenue of EUR 3.8 billion and is now making a strategy transition to become a “more focused, higher-growth nutrition business,” according to CEO Hugh McGuire in his 2025 annual report. Glanbia’s performance-ingredients division sells whey protein isolates and bioactive peptides to third-party supplement makers, generating a B2B revenue stream that diversifies from branded consumer goods. The company’s 12.4% return on capital employed and 88% operating cash-flow conversion for 2024 are further evidence of operational rigor.

8. The Bountiful Company | Private | Ronkonkoma, New York, USA

The strategic value of The Bountiful Company in the health supplements industry is its mass-marketing brand portfolio --- Nature's Bounty, Sundown Naturals and Osteo Bi-Flex --- that has shelf-space leverage across Walmart, CVS, Walgreens and Costco in the United States. The company filed an S-1 registration statement with the SEC in 2021 but remains privately held and has not revealed revenue numbers. The Bountiful Company’s value positioning resonates with the price-sensitive consumer who seeks accessibility to premium ingredients, a category that comprises approximately 35% of the U.S. supplement market by volume. The company’s 2024 launch of GLP-1 Support nutritional supplements, intended for consumers on weight-management prescription regimens, shows agility in responding to emerging consumer need-states.

9. Blackmores | Private (subsidiary of Kirin Holdings) | Sydney, Australia

Blackmores' health supplements strategy is built on naturopathic heritage and Asia-Pacific regional dominance, with the company's fish-oil and natural-health formulations deeply embedded in Australian pharmacy culture and expanding across China, Southeast Asia, and Japan following its 2023 acquisition by Kirin Holdings. The June 2023 opening of a Braeside manufacturing facility increased production capacity by 30% and introduced AI-based quality control systems --- a capital investment that signals Kirin's intent to scale Blackmores as a regional platform. Blackmores' positioning at the intersection of traditional medicine and clinical validation resonates in Asian markets where consumers prioritize natural sourcing and third-party testing.

10. Swisse Wellness | Private (subsidiary of Health & Happiness Group) | Melbourne, Australia

Swisse Wellness has built its health supplements position on premium wellness positioning and beauty-from-within formulations, with the brand achieving AUD 1 billion in global sales revenue by 2023 and certification as a B Corporation in October 2024. The company's 2022 launch of Swisse Plus in China --- featuring advanced anti-aging ingredients including Nicotinamide Riboside and L-ergothioneine --- targets the high-margin precision-nutrition segment where Chinese consumers pay premium prices for clinically validated, imported formulations. Swisse's Ultivite multivitamin line sold over 10 million bottles globally between 2022 and 2024, demonstrating brand equity in the core multivitamin category. The Health & Happiness Group's e-commerce infrastructure and cross-border trade capabilities provide Swisse with direct access to Chinese consumers through Tmall, JD.com, and VIP platforms.

M&A Activity Tracker (2023--2025)

The Health Supplements Market has experienced targeted consolidation as strategic acquirers pursue premium brands with subscription bases, proprietary formulation IP, and regional market access. Market Research Future tracks the following verified, named transactions directly relevant to the health supplements market.

Key Trend: MRFR analysis identifies vertical integration into plant-based and fermented ingredient sourcing as the dominant M&A theme, with acquirers targeting startups that own proprietary extraction technologies and organic certification pipelines. A parallel theme is the consolidation of Asia-Pacific naturopathic brands by Japanese and Chinese conglomerates seeking to capture regional demand for traditional-medicine-adjacent supplements.

R&D Investment & Innovation Signals

R&D and technology investment across the Health Supplements Market has accelerated as operators invest in AI-driven personalization, novel delivery formats, microbiome-targeted formulations, and bioavailability-enhancement technologies --- addressing the primary competitive constraints of consumer trust, formulation differentiation, and margin protection in a fragmented market.

• Amway's 2024 Gut Health solutions bundle --- combining plant protein, fiber, and probiotics --- reflects a strategic pivot from single-SKU selling to condition-based product ecosystems that increase distributor order value and customer retention in the direct-selling channel.
• Bayer AG's EUR 200 million investment in a dedicated gummy supplement manufacturing facility in Germany targets the 13.0% CAGR gummy segment and positions the company to supply halal- and vegan-certified pectin-based formulations across European and Middle Eastern markets where gelatin exclusion is a purchase prerequisite.
• Haleon's January 2025 Centrum Silver+ launch across 28 markets simultaneously --- with enhanced Vitamin K2 and magnesium glycinate targeting cognitive function in the 65-plus demographic --- demonstrates the competitive advantage of global regulatory harmonization and synchronized multi-market innovation deployment.
• Herbalife Nutrition's AI-powered personalized nutrition platform, expanded to 15 additional markets in October 2024, integrates wearable health data to generate customized supplement recommendations --- a capability that reportedly drives 30--35% higher customer retention than generic product lines.
• Nestlé Health Science's March 2025 acquisition of a fermented botanical ingredients startup for USD 340 million strengthens its vertical integration into plant-based supplement sourcing, addressing the clean-label demand shift where plant-based products grow at roughly double the rate of synthetic counterparts.